Why I'd buy Orica Ltd at this share price

Shares in explosives maker Orica Ltd (ASX:ORI) have marked time over the last few months after a stellar run earlier in the year. However, I believe that the run is far from over.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In text book fashion, new Orica Ltd (ASX: ORI) CEO Alberto Calderon took an immediate $1.7bn asset write down on joining the group in late 2015.

He then spent 2016 restructuring the business, generating future savings of $100m p.a. He is now about to reap the benefits from an improving mining cycle.

The scale of the recovery opportunity is there to see. If we look back to 2012, Orica generated sales of $6.8 billion and $1.76 of earnings per share. Five years on, group sales are running at only $5 billion and analysts are forecasting just $1.10 EPS to December 2017.

Calderon reported at the half year that mining plans were finally starting to normalise and there was a return to more sustainable strip ratios by the customer base. With that in mind, there are good grounds to believe that consensus forecasts for Orica of $5.4 billion by 2019 could seriously understate future volume and margin recovery. Any weakening of the AUD to the USD would further add to this.

Even as forecasts stand, Orica trades on a current year EV:EBITDA multiple of 9x. This doesn't appear unduly demanding for a world leading business at the low point in its cycle.

One final word regarding the dividend. The shares currently yield 2.8%. Orica's stated policy is to pay out 40%-70% of its profits as dividends through the cycle. The current ratio is at the bottom of this range, meaning that future profit growth should be reflected in even higher dividend growth.

Foolish takeaway

The author believes that the Mining Services sector is a good place to be at present, with the strength and duration of future recovery likely to surprise on the upside. Orica is a great international play on that recovery.

Motley Fool contributor James Middleweek has no financial interest in any company mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »